WBC
ALXN

Westpac Banking Corp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,213
Closed -$5.18M 857
2021
Q2
$5.18M Sell
28,213
-528
-2% -$97K 0.05% 433
2021
Q1
$4.39M Buy
28,741
+5,700
+25% +$872K 0.05% 429
2020
Q4
$3.6M Sell
23,041
-10,152
-31% -$1.59M 0.04% 464
2020
Q3
$3.8M Sell
33,193
-2,304
-6% -$264K 0.05% 403
2020
Q2
$3.98M Sell
35,497
-6,755
-16% -$758K 0.06% 393
2020
Q1
$3.79M Buy
42,252
+4,886
+13% +$439K 0.07% 342
2019
Q4
$4.04M Buy
37,366
+17,193
+85% +$1.86M 0.05% 418
2019
Q3
$1.98M Hold
20,173
0.03% 521
2019
Q2
$2.64M Buy
20,173
+4,195
+26% +$549K 0.04% 410
2019
Q1
$2.16M Buy
15,978
+673
+4% +$91K 0.04% 423
2018
Q4
$1.49M Buy
15,305
+1,743
+13% +$170K 0.03% 498
2018
Q3
$1.89M Hold
13,562
0.03% 440
2018
Q2
$1.68M Hold
13,562
0.03% 420
2018
Q1
$1.51M Hold
13,562
0.03% 428
2017
Q4
$1.62M Sell
13,562
-3,649
-21% -$436K 0.04% 392
2017
Q3
$2.41M Sell
17,211
-463
-3% -$65K 0.05% 377
2017
Q2
$2.15M Sell
17,674
-1,230
-7% -$150K 0.05% 389
2017
Q1
$2.29M Buy
18,904
+4,413
+30% +$535K 0.02% 540
2016
Q4
$1.93M Sell
14,491
-2,118
-13% -$283K 0.02% 487
2016
Q3
$2.04M Sell
16,609
-15,275
-48% -$1.87M 0.02% 465
2016
Q2
$3.63M Buy
31,884
+6,806
+27% +$775K 0.04% 429
2016
Q1
$3.49M Buy
25,078
+5,377
+27% +$749K 0.04% 393
2015
Q4
$3.76M Buy
19,701
+7,843
+66% +$1.5M 0.04% 359
2015
Q3
$1.85M Buy
11,858
+7,456
+169% +$1.17M 0.02% 453
2015
Q2
$796K Sell
4,402
-40,339
-90% -$7.29M 0.01% 506
2015
Q1
$9.09M Sell
44,741
-28,480
-39% -$5.79M 0.08% 253
2014
Q4
$13.5M Sell
73,221
-418
-0.6% -$77.3K 0.13% 180
2014
Q3
$12.2M Buy
73,639
+23,273
+46% +$3.86M 0.12% 181
2014
Q2
$7.87M Buy
50,366
+3,259
+7% +$509K 0.08% 254
2014
Q1
$7.17M Buy
47,107
+33,445
+245% +$5.09M 0.08% 252
2013
Q4
$1.82M Buy
13,662
+720
+6% +$95.8K 0.02% 498
2013
Q3
$1.5M Sell
12,942
-459
-3% -$53.3K 0.02% 493
2013
Q2
$1.24M Buy
+13,401
New +$1.24M 0.02% 510